MyMyelomaTeam

Is any MyMyelomaTeam member taking Iberdomide for relapsed myeloma?

Iberdomide is still in clinical trials and isn't yet available as a standard treatment option. So it's unlikely that many members would have access to it outside of a trial setting. Here's what's known about Iberdomide so far:

- It works similarly to Show Full Answer

Is any MyMyelomaTeam member taking Iberdomide for relapsed myeloma?

Iberdomide is still in clinical trials and isn't yet available as a standard treatment option. So it's unlikely that many members would have access to it outside of a trial setting. Here's what's known about Iberdomide so far:

- It works similarly to immunomodulatory drugs like lenalidomide, but is designed to be more powerful
- It may work even when myeloma has become resistant to older treatments
- It has shown promising early results in people who have already received many lines of treatment
- It is not yet FDA-approved and is only accessible through clinical trials

If Iberdomide sounds like something worth exploring, it's worth asking a myeloma specialist whether there are any clinical trials available that might be a good fit. Trials can sometimes be a way to access newer therapies before they're widely approved.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Treatment Options for Multiple Myeloma